Featured Research

from universities, journals, and other organizations

Virus-fighting genes linked to mutations in cancer: Genetic evidence supports role of gene family in cancer development

Date:
April 13, 2014
Source:
Wellcome Trust Sanger Institute
Summary:
All cancer-causing processes leave a distinct mutational imprint or signature on the genomes of patients. Researchers have found a major piece of biological evidence to support the role a group of virus-fighting genes has in cancer development. The mutational signature left by the cancer-causing process driven by this family of genes is found in half of all cancer types.

All cancer-causing processes leave a distinct mutational imprint or signature on the genomes of patients. A team from the Wellcome Trust Sanger Institute has found a major piece of biological evidence to support the role a group of virus-fighting genes has in cancer development. The mutational signature left by the cancer-causing process driven by this family of genes is found in half of all cancer types.

Related Articles


Researchers have found a major piece of genetic evidence that confirms the role of a group of virus-fighting genes in cancer development.

Our understanding of the biological processes that cause cancer is limited. UV light and smoking are two well-understood cancer-causing processes. Exposure to either of these processes causes distinguishable patterns of genetic damage, or 'signatures', on the genome that can lead to cancer. All cancer-causing processes leave their own distinct imprint or signature, on the genomes of cancer cells.

The APOBEC family of genes control enzymes that are believed to have evolved in humans to fight off viral infections. Scientists have speculated that these enzymes are responsible for a very distinct signature of mutations that is present in approximately half of all cancer types. Therefore, understanding the cancer-causing process behind this common genetic signature is pivotal for disease control and prevention.

The team studied the genomes of breast cancers in patients with a specific inherited deletion in two of these APOBEC genes. They found that these cancer genomes had a much greater prevalence of the distinct mutational signature that is thought to be driven by the APOBEC family of genes.

"The increased frequency of this common cancer signature in breast cancer patients with APOBEC gene abnormalities supports our theory that these enzymes play a role in generating this mutational signature," says Dr Serena Nik-Zainal, first author from the Wellcome Trust Sanger Institute.

This genetic deletion is found on chromosome 22 where the APOBEC genes, APOBEC3A and APOBEC3B, sit next to each other. Women with this genetic deletion have previously been reported to be more susceptible to breast cancer.

The team examined 923 samples of breast cancer from women from across the world and found more than 140 people with either one or two copies of the deletion on each chromosome. Breast cancer in women with the deletion had a much greater quantity of mutations of this particular genetic signature.

However, the mutational activity of the APOBEC genes appears to be a double-edged sword. This genetic deletion is much more prevalent in some populations than others: it is found in only 8 per cent of Europeans, but is present in 93 per cent of the population of Oceania. Although this deletion increases risk of cancer development, it also seems to provide a currently unknown advantage in populations where it is more common.

"In addition to this APOBEC mediated process, there appear to be many more cancer-causing mutational processes, the underlying nature of which has yet to be understood," says Professor Sir Mike Stratton, lead author and Director of the Sanger Institute. "Working out what these mutational processes are will have profound implications in the future for how we prevent and treat cancer."


Story Source:

The above story is based on materials provided by Wellcome Trust Sanger Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Serena Nik-Zainal, David C Wedge, Ludmil B Alexandrov, Mia Petljak, Adam P Butler, Niccolo Bolli, Helen R Davies, Stian Knappskog, Sancha Martin, Elli Papaemmanuil, Manasa Ramakrishna, Adam Shlien, Ingrid Simonic, Yali Xue, Chris Tyler-Smith, Peter J Campbell, Michael R Stratton. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nature Genetics, 2014; DOI: 10.1038/ng.2955

Cite This Page:

Wellcome Trust Sanger Institute. "Virus-fighting genes linked to mutations in cancer: Genetic evidence supports role of gene family in cancer development." ScienceDaily. ScienceDaily, 13 April 2014. <www.sciencedaily.com/releases/2014/04/140413135912.htm>.
Wellcome Trust Sanger Institute. (2014, April 13). Virus-fighting genes linked to mutations in cancer: Genetic evidence supports role of gene family in cancer development. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2014/04/140413135912.htm
Wellcome Trust Sanger Institute. "Virus-fighting genes linked to mutations in cancer: Genetic evidence supports role of gene family in cancer development." ScienceDaily. www.sciencedaily.com/releases/2014/04/140413135912.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins